RANI

Q: What is the price of Rani Therapeutics Holdings Inc (RANI) today?

A cotação de Rani Therapeutics Holdings Inc (RANI) hoje está em $ 0.97, com uma variação de The stock began the year trading around $ 1.35 and is currently priced at $ 0.97. negociando na casa dos $ 1.35 e hoje está em $ 0.97. Acompanhe o and track broader market trends directly on the platform.

Q: When does Rani Therapeutics Holdings Inc (RANI) pay dividends?

Rani Therapeutics Holdings Inc (RANI) did not pay dividends over the past year.

Q: Is Rani Therapeutics Holdings Inc (RANI) a good investment?

Atualmente, Rani Therapeutics Holdings Inc (RANI) está cotada a $ 0.97, com um P/L de -10.28, This represents a -75,000,256% premium compared to its historical average P/E. uma variação de 38.9 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 38.90%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Rani Therapeutics Holdings Inc

Price

$ 0.97

return (12m)

38.90%

p/e

-10.28

p/bv

2.55

DIVIDEND YIELD

0.00%

RANI price

RANI

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment RANI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.66%

3 months

-24.04%

1 year

38.90%

2 years

-81.48%

5 years

0.00%

10 years

0.00%

Fundamentals RANI

review the fundamentals of Rani Therapeutics Holdings Inc shares

P/E

-10.28

Sector: 16.94 Industry: 16.94

P/S (PSR)

72.49

Sector: 5.29 Industry: 5.29

P/BV

2.55

Sector: 2.14 Industry: 2.14

DIVIDEND YIELD (DY)

0.00%

Sector: 0.68% Industry: 0.68%

ROA

-17.57%

Sector: -0.05% Industry: -0.05%

ROE

-24.81%

Sector: 1.71% Industry: 1.71%

ROIC

-202.82%

Sector: -171.43% Industry: -171.43%

NET MARGIN

-100.00%

Sector: 3.03% Industry: 3.03%

GROSS MARGIN

100.00%

Sector: 31.91% Industry: 31.91%

OPERATING MARGIN

-100.00%

Sector: 4.80% Industry: 4.80%

EV/EBITDA

-12.39

Sector: 8.77 Industry: 8.77

EV/EBIT

-12.12

Sector: 5.95 Industry: 5.95

PRICE-TO-ASSETS

1.81

Sector: 1.02 Industry: 1.02

BVPS

0.42

Sector: 10.34 Industry: 10.34

EPS

-0.11

Sector: 0.29 Industry: 0.29

EQUITY-TO-ASSETS RATIO

0.71

Sector: 0.43 Industry: 0.43

LIABILITIES / ASSETS

0.29

Sector: 0.53 Industry: 0.53

CAGR REVENUE 5 YEARS

-9.73%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

28.92%

Sector: - Industry: -

Fundamentals RANI

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	58.14	6.39	10.99%	0.34%	$ 1.56 T	47.54%
INTR	1.82	0.05	2.75%	1.93%	$ 2.61 B	9.10%
PBR	20.56	1.50	7.32%	5.98%	$ 128.43 B	26.41%
VALE	36.80	1.86	5.04%	6.21%	$ 69.67 B	20.45%
PLTR	368.48	37.49	10.17%	0.00%	$ 320.77 B	53.32%
SHEL	42.38	1.38	3.26%	3.39%	$ 241.31 B	8.17%
BDORY	50.94	0.62	1.22%	2.81%	$ 23.35 B	6.90%
MAIN	93.73	1.48	1.58%	7.89%	$ 4.59 B	66.69%
NSRGY	51.04	6.13	12.00%	3.44%	$ 254.14 B	8.73%
ENB	93.13	2.44	2.62%	4.92%	$ 120.69 B	7.95%
PBR-A	18.56	1.36	7.32%	5.99%	$ 115.93 B	26.41%
ITUB	3.14	2.07	66.01%	1.99%	$ 86.92 B	11.88%
UNH	56.95	3.40	5.96%	2.24%	$ 357.62 B	5.62%
BBSEY	33.26	5.63	16.92%	11.45%	$ 13.61 B	100.00%
SAN	28.15	1.36	4.85%	1.73%	$ 177.52 B	35.32%
TTE	34.42	1.60	4.64%	6.09%	$ 199.98 B	11.73%
RACE	119.11	12.13	10.18%	1.32%	$ 56.85 B	22.34%
IONQ	23.93	3.86	16.14%	0.00%	$ 19.27 B	100.00%
TD	61.59	1.98	3.22%	2.86%	$ 180.84 B	24.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

RANI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Rani Therapeutics Holdings Inc (United States) is listed on the Nasdaq and has a market capitalization of $105.84 Millions, with shareholders equity totaling $41.51 Millions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Rani Therapeutics Holdings Inc reported $1.63 Million in revenue, generating net income of $-29.66 Millions.

Key financial metrics include a P/E ratio of -10.28, a price-to-book (P/B) ratio of 2.55, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RANI.

Market cap

$ 105.84 Millions

Net worth

$ 41.51 Millions

$ 41,510,000.00

Assets

$ 58.62 Millions

$ 58,620,000.00

Total Shares Outstanding

98.00 Millions

98,000,000

Average Daily Trading Volume

$ 1.11 Million

$ 1,106,688.78

Sector

Others

Industry

Others

RANI

RANI revenue and profits

Financial Results RANI

DRAG THE FRAME TO SEE MORE DATA

RANI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

SHG - Shinhan Financial Group Co Ltd

$ 63.62 70,62% (12M)

P/E

0.01

2.45%

ROE

7.11%

P/BV

0.00

CRERF - Carrefour SA

$ 20.10 43,14% (12M)

P/E

1.47

6.35%

ROE

9.72%

P/BV

0.14

UNH - UnitedHealth Group Incorporated

$ 391.13 27,30% (12M)

P/E

56.95

2.24%

ROE

5.96%

P/BV

3.40

STLA - Stellantis NV

$ 7.41 --30,55% (12M)

P/E

-0.92

0.00%

ROE

-37.27%

P/BV

0.34

CCOEY - Capcom Co Ltd ADR

$ 9.51 --32,49% (12M)

P/E

0.15

1.47%

ROE

20.55%

P/BV

0.03

COR - Cencora Inc.

$ 261.87 --9,66% (12M)

P/E

30.62

0.89%

ROE

45.78%

P/BV

14.02

SHEL - Shell PLC ADR

$ 88.59 39,49% (12M)

P/E

42.38

3.39%

ROE

3.26%

P/BV

1.38

SSNLF - Samsung Electronics Co Ltd

$ - -0,00% (12M)

P/E

19.25

1.58%

ROE

10.38%

P/BV

2.00